New brain decoder offers hope for improving communication in aphasia

People with aphasia-a brain disorder affecting about a million people in the U.S.-struggle to turn their thoughts into words and comprehend spoken language.

Gilead and Terray to develop small-molecule therapies

The partnership leverages Terray’s AI-driven platform designed to enhance drug discovery through high-throughput chemical experimentation. Credit: Collagery/Shutterstock. Gilead Sciences has entered a strategic partnership with

December 18, 2024

clock.bio Raises $5.3M to Decode Human Rejuvenation, Develop Anti-Aging Therapies

What You Should Know: – clock.bio, a healthspan biotechnology company based at the Milner Therapeutics Institute in Cambridge, has secured $5.3M in seed funding to

October 10, 2024

Novo Nordisk’s ocedurenone Phase III flop costs company $816m

Novo Nordisk acquired ocedurenone in a $1.3bn deal in 2023. Image credit: oleschwander / Shutterstock. Novo Nordisk has said it will take a DKr5.7bn ($816m)

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.